Detalles de la búsqueda
1.
First-site-metastasis pattern in patients with inoperable stage III NSCLC treated with concurrent chemoradiotherapy with or without immune check-point inhibition: a retrospective analysis.
Strahlenther Onkol
; 2023 Nov 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-37975883
2.
Pooled analysis on image-guided moderately hypofractionated thoracic irradiation in inoperable node-positive/recurrent patients with non-small cell lung cancer with poor prognostic factors and severely limited pulmonary function and reserve.
Cancer
; 128(12): 2358-2366, 2022 06 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35417563
3.
Planning target volume as a predictor of disease progression in inoperable stage III non-small cell lung cancer patients treated with chemoradiotherapy and concurrent and/or sequential immune checkpoint inhibition.
Invest New Drugs
; 40(1): 163-171, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34351518
4.
Treatment patterns and prognosis of patients with inoperable stage III NSCLC after completion of concurrent chemoradiotherapy ± immune checkpoint inhibition: a decade-long single-center historical analysis.
J Cancer Res Clin Oncol
; 149(7): 3267-3276, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35915184
5.
Five years after PACIFIC: update on multimodal treatment efficacy based on real-world reports.
Expert Opin Investig Drugs
; 32(3): 187-200, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36780358
6.
Concurrent/sequential versus sequential immune checkpoint inhibition in inoperable large stage III non-small cell lung cancer patients treated with chemoradiotherapy: a prospective observational study.
J Cancer Res Clin Oncol
; 149(10): 7393-7403, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-36939927
7.
Prospective evaluation of immunological, molecular-genetic, image-based and microbial analyses to characterize tumor response and control in patients with unresectable stage III NSCLC treated with concurrent chemoradiotherapy followed by consolidation therapy with durvalumab (PRECISION): protocol for a prospective longitudinal biomarker study.
Transl Lung Cancer Res
; 11(7): 1503-1509, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35958344
8.
Combination of pembrolizumab with radiotherapy can change treatment paradigm in metastatic "non-driver" non-small-cell lung cancer: Assembling a path.
Clin Respir J
; 15(10): 1139-1144, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34143575
Resultados
1 -
8
de 8
1
Próxima >
>>